CRSP logo

CRISPR Therapeutics AG (CRSP) CAPEX

Annual CAPEX

$1.90 M
-$10.07 M-84.12%

December 31, 2024

Summary

Performance

1-Year Change

-84.12%

3-Year Change

-97.67%

5-Year Change

-71.56%

15-Year Change

-75.67%

CRSP CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.11%
CRSP annual capital expenditures is higher than 45.11% of companies in Healthcare sector

High & Low

All-time High

$81.70 M
CRSP annual capital expenditures is currently -97.67% below its historical high of $81.70 million

3-Year Low

$1.90 M
CRSP annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
CRSP previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
CRSP next annual earnings announcement has not yet been scheduled

OtherCRSPcash flowmetrics:

Annual FCF

-$144.68 M
CRSP annual free cash flow is -$144.68 million

Annual CFO

-$142.77 M
CRSP annual cash flow from operations is -$142.77 million

Annual CFI

-$280.48 M
CRSP annual cash flow from investing activities is -$280.48 million

Annual CFF

$331.98 M
CRSP annual cash flow from financing activities is $331.98 million

Quarterly CAPEX

$254.00 K
+$35.00 K+15.98%

December 31, 2024

Summary

Performance

3-Month Change

+15.98%

1-Year Change

-64.07%

3-Year Change

-64.07%

5-Year Change

-64.07%

CRSP Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.59%
CRSP quarterly capital expenditures is higher than 39.59% of companies in Healthcare sector

High & Low

All-time High

$37.05 M
CRSP quarterly capital expenditures is currently -99.31% below its historical high of $37.05 million

3-Year Low

$219.00 K
CRSP quarterly capital expenditures is currently +15.98% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
CRSP previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
CRSP next earnings announcement is scheduled for May 8, 2025

OtherCRSPcash flowmetrics:

Quarterly FCF

-$50.28 M
CRSP quarterly free cash flow is -$50.28 million

Quarterly CFO

-$50.03 M
CRSP quarterly cash flow from operations is -$50.03 million

Quarterly CFI

$105.83 M
CRSP quarterly cash flow from investing activities is $105.83 million

Quarterly CFF

$16.88 M
CRSP quarterly cash flow from financing activities is $16.88 million

TTM CAPEX

$1.90 M
-$484.00 K-20.29%

December 31, 2024

Summary

Performance

3-Month Change

-20.29%

1-Year Change

-64.02%

3-Year Change

-64.02%

5-Year Change

-64.02%

CRSP TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.08%
CRSP TTM capital expenditures is higher than 42.08% of companies in Healthcare sector

High & Low

All-time High

$90.03 M
CRSP TTM capital expenditures is currently -97.89% below its historical high of $90.03 million

3-Year Low

$1.90 M
CRSP TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
CRSP previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
CRSP next earnings announcement is scheduled for May 8, 2025

OtherCRSPcash flowmetrics:

TTM FCF

-$144.68 M
CRSP TTM free cash flow is -$144.68 million

TTM CFO

-$142.77 M
CRSP TTM cash flow from operations is -$142.77 million

TTM CFI

-$280.48 M
CRSP TTM cash flow from investing activities is -$280.48 million

TTM CFF

$331.98 M
CRSP TTM cash flow from financing activities is $331.98 million

CRSP CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-84.1%-64.1%-64.0%
3 y3 years-97.7%-64.1%-64.0%
5 y5 years-71.6%-64.1%-64.0%

CRSP CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.7%at low-98.3%+16.0%-97.9%at low
5 y5-year-97.7%at low-99.3%+16.0%-97.9%at low
alltimeall time-97.7%+64.7%-99.3%+23.9%-97.9%+719.4%

CRISPR Therapeutics AG CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
$1.90 M(-84.1%)
$254.00 K(+16.0%)
$1.90 M(-20.3%)
Sep 2024
-
$219.00 K(-69.0%)
$2.38 M(-54.9%)
Jun 2024
-
$707.00 K(-1.9%)
$5.28 M(-45.1%)
Mar 2024
-
$721.00 K(-2.3%)
$9.63 M(-19.5%)
Dec 2023
$11.97 M(-67.8%)
$738.00 K(-76.3%)
$11.97 M(-31.3%)
Sep 2023
-
$3.12 M(-38.3%)
$17.42 M(-14.3%)
Jun 2023
-
$5.05 M(+65.3%)
$20.32 M(-18.4%)
Mar 2023
-
$3.06 M(-50.6%)
$24.90 M(-33.1%)
Dec 2022
$37.19 M(-54.5%)
$6.19 M(+2.9%)
$37.19 M(-7.4%)
Sep 2022
-
$6.02 M(-37.5%)
$40.18 M(-43.6%)
Jun 2022
-
$9.63 M(-37.3%)
$71.21 M(-20.9%)
Mar 2022
-
$15.35 M(+67.2%)
$90.03 M(+10.2%)
Dec 2021
$81.70 M(+345.1%)
$9.18 M(-75.2%)
$81.70 M(+3.7%)
Sep 2021
-
$37.05 M(+30.2%)
$78.76 M(+66.7%)
Jun 2021
-
$28.45 M(+305.0%)
$47.23 M(+111.0%)
Mar 2021
-
$7.02 M(+12.6%)
$22.39 M(+22.0%)
Dec 2020
$18.36 M
$6.24 M(+13.0%)
$18.36 M(+40.4%)
Sep 2020
-
$5.52 M(+53.2%)
$13.07 M(+30.6%)
DateAnnualQuarterlyTTM
Jun 2020
-
$3.60 M(+20.5%)
$10.01 M(+16.7%)
Mar 2020
-
$2.99 M(+214.2%)
$8.58 M(+28.3%)
Dec 2019
$6.68 M(+141.0%)
$952.00 K(-61.3%)
$6.68 M(-0.7%)
Sep 2019
-
$2.46 M(+13.2%)
$6.73 M(+35.6%)
Jun 2019
-
$2.17 M(+98.2%)
$4.97 M(+49.8%)
Mar 2019
-
$1.10 M(+9.7%)
$3.31 M(+19.5%)
Dec 2018
$2.77 M(-64.5%)
$1.00 M(+43.9%)
$2.77 M(+40.2%)
Sep 2018
-
$695.00 K(+32.9%)
$1.98 M(-53.8%)
Jun 2018
-
$523.00 K(-5.8%)
$4.28 M(-15.9%)
Mar 2018
-
$555.00 K(+170.7%)
$5.08 M(-34.9%)
Dec 2017
$7.81 M(+159.1%)
$205.00 K(-93.2%)
$7.81 M(-0.3%)
Sep 2017
-
$2.99 M(+125.1%)
$7.84 M(+23.4%)
Jun 2017
-
$1.33 M(-59.5%)
$6.35 M(+4.7%)
Mar 2017
-
$3.29 M(+1340.8%)
$6.07 M(+101.2%)
Dec 2016
$3.02 M(+161.4%)
$228.00 K(-84.9%)
$3.02 M(+8.2%)
Sep 2016
-
$1.51 M(+44.1%)
$2.79 M(+118.0%)
Jun 2016
-
$1.05 M(+351.3%)
$1.28 M(+451.3%)
Mar 2016
-
$232.00 K
$232.00 K
Dec 2015
$1.15 M
-
-

FAQ

  • What is CRISPR Therapeutics AG annual capital expenditures?
  • What is the all time high annual CAPEX for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG annual CAPEX year-on-year change?
  • What is CRISPR Therapeutics AG quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG quarterly CAPEX year-on-year change?
  • What is CRISPR Therapeutics AG TTM capital expenditures?
  • What is the all time high TTM CAPEX for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG TTM CAPEX year-on-year change?

What is CRISPR Therapeutics AG annual capital expenditures?

The current annual CAPEX of CRSP is $1.90 M

What is the all time high annual CAPEX for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual capital expenditures is $81.70 M

What is CRISPR Therapeutics AG annual CAPEX year-on-year change?

Over the past year, CRSP annual capital expenditures has changed by -$10.07 M (-84.12%)

What is CRISPR Therapeutics AG quarterly capital expenditures?

The current quarterly CAPEX of CRSP is $254.00 K

What is the all time high quarterly CAPEX for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly capital expenditures is $37.05 M

What is CRISPR Therapeutics AG quarterly CAPEX year-on-year change?

Over the past year, CRSP quarterly capital expenditures has changed by -$453.00 K (-64.07%)

What is CRISPR Therapeutics AG TTM capital expenditures?

The current TTM CAPEX of CRSP is $1.90 M

What is the all time high TTM CAPEX for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high TTM capital expenditures is $90.03 M

What is CRISPR Therapeutics AG TTM CAPEX year-on-year change?

Over the past year, CRSP TTM capital expenditures has changed by -$3.38 M (-64.02%)